As of 2025-05-03, the Fair Value of Vascular Biogenics Ltd (VBLT) is -1.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.16 USD, the upside of Vascular Biogenics Ltd is -758.65%.
With the market price of 0.16 USD and our fair value calculation, Vascular Biogenics Ltd (VBLT) is not a good investment. Investing in VBLT stocks now will result in a potential loss of 758.65%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -20.50 | -19.40 | -24.23 | -29.92 | -32.30 | -25.27 |
| YoY growth | -102.17% | 5.37% | -24.90% | -23.48% | -7.97% | -30.63% |
| Market Cap (mil) | 12.11 |
| P/E | |
| Forward P/E |
| EPS | -0.21 |
| Avg earnings growth rate | -30.63% |
| TTM earnings | -15.96 |